The double-positive CD14+CD16+-MΦ subset frequency increases in systemic inflammation and inflammatory diseases such as rheumatoid arthritis (RA), Crohn’s disease, Eales’ disease and asthma [17–19]. The gene discussed is CD14; the disease is rheumatoid arthritis.